The Effect of Low or High Dietary Fiber Diet on Volatile Organic Compounds in Exhaled Breath of Healthy Individuals
FIBRE-MATCH
Characterization of Fiber-degrading Microbiota in Individuals Without Gastrointestinal Diseases
2 other identifiers
interventional
20
0 countries
N/A
Brief Summary
The aim of this crossover intervention study is to evaluate the volatile organic compounds (VOCs) present in participants at baseline and how these levels change after consuming either a low- or high-dietary fiber diet for three days. This study will involve adults, 18-65 years old, without any gastrointestinal diseases. The primary objectives are to characterize baseline VOC profiles, assess changes in these profiles after a short-term dietary fiber intervention, determine if specific VOC patterns correlate with dietary fiber intake, and identify the time points at which VOC levels peak. This information will help establish the optimal timing for breath sampling and potentially help us understand how VOC patterns relate to dietary fiber consumption and degradation. We expect that the high-dietary fiber diet will lead to a more significant increase in VOC levels and potentially a distinct VOC profile compared to the low-dietary fiber diet. Each participant will serve as their own control, allowing for within-subject comparisons of VOC levels at baseline and after both dietary fiber interventions. Participants will receive a whole-food product that is rich in dietary fiber and will consume either a low-fiber diet (10 g/day) or a high-fiber diet (40 g/day) for three days. On the first day of each intervention, participants will also ingest a pH capsule to monitor gastrointestinal pH continuously throughout the three days. After a three-week washout period, participants will cross over to the other intervention arm and undergo another round of gastrointestinal pH monitoring. In addition to the dietary intervention, participants will complete food and health questionnaires to assess their habitual fiber intake and dietary habits. Fecal samples will be collected for in vitro fermentation to functionally profile the gut microbiota by assessing fecal VOCs, short-chain fatty acids (SCFA), and the microbial enzymatic activity and their pH-dependent modulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 13, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
May 19, 2026
May 1, 2026
6 months
May 13, 2026
May 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of a 3-day low fiber diet compared to a 3-day high fiber diet on the Volatile Organic Compound profiles in exhaled breath
Volatile Organic Compound profiles in produced by the 3-day low fiber diet intervention compared to the profiles produced by the 3-day high fiber diet, with a 3-week washout inbetween
5 weeks
Secondary Outcomes (8)
Effect of a low fiber diet on Volatile Organic Compound profiles after 4 hours
4 hours
Effect of a low fiber diet on Volatile Organic Compound profiles after 6 hours
6 hours
Effect of a low fiber diet on Volatile Organic Compound profiles after 8 hours
8 hours
Effect of a high fiber diet on Volatile Organic Compound profiles after 4 hours
4 hours
Effect of a high fiber diet on Volatile Organic Compound profiles after 6 hours
6 hours
- +3 more secondary outcomes
Other Outcomes (2)
Fecal Volatile Organic Compound profiles
1 week
SCFA
1 Week
Study Arms (2)
Low Fiber Diet, Then High Fiber Diet
EXPERIMENTALParticipants will receive a whole food dietary fiber product to consume 10g of dietary fiber per day over a total of 3 days, equal to a high fiber diet. After a washout period of 3 weeks, they then receive the same whole food dietary fiber product, to consume 40g of dietary fiber per day in a total of 3 days, equal to a high fiber diet.
High Fiber Diet, Then Low Fiber Diet
EXPERIMENTALParticipants will receive a whole food dietary fiber product to consume 40g of dietary fiber per day over a total of 3 days, equal to a high fiber diet. After a washout period of 3 weeks, they then receive the same whole food dietary fiber product, to consume 10g of dietary fiber per day in a total of 3 days, equal to a high fiber diet.
Interventions
Dietary Intervention: Low Fiber Diet Whole food dietary fiber product, 10g of dietary fiber consumed per day for 3 days Dietary Intervention: High Fiber Diet Whole food dietary fiber product, 40g of dietary fiber consumed per day for 3 days
Dietary Intervention: High Fiber Diet Whole food dietary fiber product, 40g of dietary fiber consumed per day for 3 days Dietary Intervention: Low Fiber Diet Whole food dietary fiber product, 10g of dietary fiber consumed per day for 3 days
Eligibility Criteria
You may qualify if:
- Signed informed consent obtained prior to any study-related procedures.
- Willingness to refrain from regular consumption of prebiotic or probiotic products, as well as medications known to affect gastrointestinal function, for at least four weeks prior to the study visits.
You may not qualify if:
- History of complicated gastrointestinal surgery.
- Presence of a gastrointestinal diagnosis or any condition that, in the opinion of the principal investigator, may influence the study outcomes.
- Current diagnosis of a psychiatric disorder.
- Systemic use of antibiotics or steroid medications within the past 3 months.
- Frequent use of NSAIDs (non-steroidal anti-inflammatory drugs) within the 2 months preceding the study visit.
- Regular consumption of prebiotic or probiotic products within the past 4 weeks.
- Alcohol or substance abuse.
- Current smoking or use of nicotine pouches.
- Frequent use of laxatives, antidiarrheal agents, or anticholinergic medications within the 12 weeks preceding the study visit.
- Pregnancy or breastfeeding.
- Respiratory disease or infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Örebro University, Swedenlead
- University of Helsinkicollaborator
- European Innovation Councilcollaborator
Study Officials
- STUDY DIRECTOR
Robert Brummer, Professor
Örebro University, Sweden
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2026
First Posted
May 19, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
May 19, 2026
Record last verified: 2026-05